IART Q1 2019 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q1 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$360M+0.7% YoY

Gross Profit

$231M64.2% margin

Operating Income

$32M9.0% margin

Net Income

$33M9.1% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

-6.2%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$13M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$1.8B

Stockholders' Equity

$1.4B

Cash & Equivalents

$157M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$360M	$357M	+0.7%
Gross Profit	$231M	$213M	+8.4%
Operating Income	$32M	$26M	+26.3%
Net Income	$33M	$11M	+198.0%

Revenue Segments

Private Label

$600,000100%

Geographic Segments

UNITED STATES

$257M71%

Europe

$49M14%

Asia Pacific

$36M10%

Rest Of World

$19M5%